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Cryoballoon ablation of the pulmonary veins (CAPV) has been demonstrated to be non-inferior to
radiofrequency (RF) ablation for paroxysmal atrial ﬁbrillation (AFib). As CAPV requires a larger trans-
septal sheath than RF ablation, it can be challenging in the presence of an Amplatzer™ Septal Occluder
(ASO) device. Real-time three-dimensional transesophageal echocardiography (RT3DTEE) provides
enhanced visualization of various complex cardiac defects and has revolutionized interventional pro-
cedures by guiding catheter positioning. We describe successful RT3DTEE guided transseptal puncture
for CAPV of paroxysmal AFib in the presence of an ASO in a 53-year-old male.
Copyright © 2016, Indian Heart Rhythm Society. Production and hosting by Elsevier B.V. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
A 53-year-old man presented with drug refractory paroxysmal
atrial ﬁbrillation (AFib). His history included coronary artery dis-
ease, cryptogenic stroke with a large persistent foramen ovale,
which was closed with a 30 mm Amplatzer™ Multi-Fenestrated
Septal Occluder (ASO; St. Jude Medical, Inc., St. Paul, MN, USA) at
the age of 50 years. He developed paroxysmal AFib and failed
amiodarone therapy. He complained of extreme fatigue during AFib
limiting his activities. Cryoballoon ablation of the pulmonary veins
(CAPV) was recommended to treat his paroxysmal AFib.
2. Case report
During CAPV, catheter movements were guided by real-time
three-dimensional transesophageal echocardiography (RT3DTEE)
to visualize the ASO. An appropriate site for transseptal puncture
(TSP) was found just anterior and inferior to the ASO. An 8.5 Fr Medicine, Frederik Meijer
ichigan NE, Grand Rapids, MI
.
rg (N.T. Chalfoun).
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Canada) and a 71 cm radiofrequency (RF) transseptal needle
(NRG™ Transseptal Needle; Baylis Medical) were used for TSP. An
Amplatz Super Stiff™ guidewire (Boston Scientiﬁc, Marlborough,
MA, USA) was used to allow for signiﬁcant support needed to ex-
change the FlexCath® Steerable Sheath (Medtronic, Minneapolis,
MN, USA) over the wire (Fig. 1). The transseptal sheath was
exchanged for a 15 F cryoablation FlexCath® sheath (Fig. 2). A 28
mm cryoballoon with a 15 mm Achieve™ Mapping Catheter
(Medtronic, Minneapolis, MN, USA) was advanced into the left
atrium. Intracardiac echocardiography (ICE) was used throughout
the procedure to verify pulmonary vein (PV) balloon occlusion and
rule out pericardial effusion. Due to the limited space for TSP of the
native septum, ICE and RT3DTEE were used for catheter positioning
anterior and inferior to the ASO.
The patient had four PVs with normal anatomy. Lesions were
applied to all PVs with phrenic monitoring throughout, which
showed no evidence of phrenic slowing. Entrance and exit block
were performed on the veins and following this, all veins were
found to be free of signal. The patient was discharged after over-
night observation without any complications. At his three-month
follow up visit, he did not have any recurrent AFib.
CAPV has been shown to be non-inferior to RF ablation for
treating paroxysmal AFib [1,2]. RF ablation of AFib has been shownElsevier B.V. This is an open access article under the CC BY-NC-ND license (http://
Fig. 1. 3DTEE image demonstrating the transseptal puncture site with the FlexCath® sheath in close proximity anterior and inferior to the ASO.
Fig. 2. Left anterior oblique (LAO) projection demonstrating ﬂuoroscopic images of the
FlexCath® sheath inferior to the ASO.
J.A. Rind et al. / Indian Pacing and Electrophysiology Journal 16 (2016) 169e171170to be safe and effective in patients with atrial septal defect closure
devices [3]. However, CAPV has not been previously reported as a
rhythm control strategy for paroxysmal AFib in the presence of an
ASO. Due to the large FlexCath® sheath (15 F) required for TSP, it
was unclear whether CAPV would be feasible in the presence of anASO. Prior reports have demonstrated the feasibility of TSP using RF
ablation with up to a maximum sheath size of 8.5 F [4]. This case
demonstrates that TSP can be performed in portions of the native
septum under RT3DTEE guidance. Fewer artifacts were noted on
RT3DTEE than on ICE.
3. Conclusions
CAPV for paroxysmal AFib in the presence of an ASO was per-
formed safely and effectively in one patient, and provides electro-
physiologists with an additional option to treat atrial arrhythmias
in patients with intracardiac devices. The larger sheath combined
with the ﬂexibility of the FlexCath® sheath made it possible to
maneuver across a thick septumwith an ASOwithout difﬁculty and
allowed for improved torque. RT3DTEE was useful in selecting a
safe transseptal site without signiﬁcant artifact. The use of CAPV for
AFib in patients with closure devices with TSP under RT3DTEE
guidance is possible in such patients.
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